查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363067

胃腸滯留給藥系統外包市場規模、佔有率和趨勢分析報告：按劑型、地區和細分市場預測，2023-2030年

Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

胃腸滯留給藥系統外包市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球胃腸道滯留給藥系統外包市場規模將達22.7億美元。

預計2023年至2030年該市場將以6.99%的年複合成長率擴張。對以患者為中心的解決方案的日益關注和對外包的需求不斷成長是推動市場擴張的一些關鍵要素。此外，對局部藥物輸送的日益關注預計將促進市場成長。

胃腸滯留藥物遞送系統適用用途胃腸道內的局部藥物遞送。對於消化性潰瘍、食道症 (GERD) 和發炎性腸道疾病(IBD) 等疾病尤其如此。此外，奈米技術、3D 列印和數位健康等先進技術正在胃滯留藥物輸送系統中探索，以提高藥物傳輸準確性、監測和患者參與度。

COVID-19大流行對胃腸道滯留給藥系統外包市場產生了重大影響。由於封鎖、旅行限制和患者招募問題，許多臨床試驗被推遲或推遲。這阻礙了新型胃滯留藥物輸送系統的開發和測試。此外，疫情擾亂了全球供應鏈，導致原料和工業零件取得困難。此要素影響了胃腸滯留給藥系統的生產和發展。

要素營運公司推出新產品、併購策略性措施不斷增加，以及研發項目投資增加等因素預計也將推動未來年度的市場成長。例如，2022 年 11 月，Lonza 宣布推出 Capsugel Enprotect，這是一種專為腸內給藥而設計的新型膠囊解決方案。與傳統膠囊不同，這種創新設計在通過胃的過程中保持完整，僅在腸道中釋放其內容物。 Capsugel Enprotect 是一種無塗層膠囊，由於不需要塗層或密封膠囊，因此有可能簡化藥品製造流程。

胃腸滯留給藥系統外包市場報告重點

  • 以劑型分類，錠劑佔據最大的銷售佔有率，2022 年將超過 38%。錠劑是眾所周知且廣泛使用的劑型。由於錠劑適應性強，可用於控制釋放、緩釋、標靶給藥等多種製劑方式，是胃滯留給藥系統的理想選擇。
  • 預計膠囊在預測期內將佔據重要的市場佔有率。改良釋放和特殊塗層等膠囊技術的發展允許開發更先進的胃滯留組合物。這些進步可能會增加對以膠囊給藥系統為中心的外包服務的需求。
  • 2022 年，北美地區的銷售佔有率最大，超過 47%。這得歸功於該地區先進的醫藥產業、強大的研發能力、高市場需求和完善的醫療基礎設施。
  • 同時，亞太地區預計將在未來年度對市場收益做出重大貢獻。具有成本效益的外包、政府的支持和激勵、不斷成長的醫療保健需求以及技術進步是推動該地區市場成長的關鍵要素。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場趨勢及展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 營商環境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章 業務分析

  • 胃腸滯留給藥系統外包：2022 年及 2030 年劑型變化分析
  • 錠劑
  • 液體
  • 微球
  • 膠囊
  • 其他

第5章 區域業務分析

  • 區域市場簡介
  • 北美洲
    • 2018-2030年北美胃腸滯留給藥系統外包市場
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲胃腸滯留給藥系統外包市場，2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區胃腸滯留給藥系統外包市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲胃腸滯留給藥系統外包市場，2018-2030
    • 主要國家趨勢
    • 法律規範
    • 競爭場景
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • MEA胃腸滯留給藥系統外包市場，2018-2030年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 公司分類
  • 策略規劃
    • 收購
    • 合作
    • 宣布新平台
    • 其他
  • 公司簡介/名單
    • Catalent
    • Lonza
    • Evonik
    • Colorcon
    • Quotient Sciences
    • Aptar Pharma
    • Aenova Group
    • Evotec
    • Ashland
    • Vectura Group Ltd.
Product Code: GVR-4-68040-122-6

Gastroretentive Drug Delivery Systems Outsourcing Market Growth & Trends:

The global gastroretentive drug delivery systems outsourcing market size is expected to reach USD 2.27 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.99% from 2023 to 2030. Rising focus on patient-centric solutions and growing outsourcing demand are some of the key factors driving market expansion. Furthermore, an increased focus on localized drug delivery is expected to boost market growth.

Gastroretentive drug delivery systems are indicated for localized drug delivery applications in the gastrointestinal tract. This is particularly true for disorders such as peptic ulcers, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD). Moreover, the use of advanced technologies such as nanotechnology, 3D printing, and digital health in gastroretentive drug delivery systems has been investigated in order to improve drug delivery accuracy, monitoring, and patient involvement.

The COVID-19 pandemic significantly impacted the market for gastroretentive drug delivery systems outsourcing. Many clinical trials were postponed or delayed as a result of lockdowns, travel restrictions, and patient recruitment issues. This hampered the development and testing of novel gastroretentive medication delivery systems. Moreover, the pandemic disrupted worldwide supply chains, disrupting the availability of raw materials and industrial components. This factor had an influence on the manufacturing and development of gastroretentive drug delivery systems.

Factors such as rising strategic initiatives in the form of new product launches, partnerships, mergers & acquisitions by key operating companies, and growing investments in R&D programs are other factors expected to boost market growth in the coming years. For instance, in November 2022, Lonza introduced a new capsule solution known as Capsugel Enprotect, designed for intestinal drug delivery. Unlike conventional capsules, this innovative design remains intact during stomach transit and only releases its contents in the intestine. Capsugel Enprotect is a coating-free capsule that could potentially simplify the drug manufacturing process by eliminating the need for additional capsule coating or sealing.

Gastroretentive Drug Delivery Systems Outsourcing Market Report Highlights:

  • Based on dosage form, the tablets segment accounted for the largest revenue share of over 38% in 2022. Tablets are a well-known and extensively used dosage type. Because of their adaptability, they can be used in various formulation methods, such as controlled release, sustained release, and targeted administration, making them ideal for gastroretentive drug delivery systems
  • The capsule segment is expected to account for a significant market share in the forecast period. Capsule technology developments, such as modulated release and specialized coatings, enable the development of more advanced gastroretentive compositions. These advancements may enhance the demand for outsourcing services centered on capsule-based medication delivery systems
  • North America captured the largest revenue share of over 47% in 2022. This is attributed to the region's advanced pharmaceutical industry, strong research and development capabilities, high market demand, and an established healthcare infrastructure
  • On the other hand, the Asia Pacific region is expected to contribute significantly to the market revenue in the coming years. Cost-effective outsourcing, government support and incentives, rising healthcare needs, and technological advancements are some of the major factors driving the regional market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Dosage Form Business Analysis

  • 4.1. Gastroretentive Drug Delivery Systems Outsourcing: Dosage Form Movement Analysis, 2022 & 2030
  • 4.2. Tablets
    • 4.2.1. Tablets Market, 2018 - 2030 (USD Million)
  • 4.3. Liquid
    • 4.3.1. Liquid Market, 2018 - 2030 (USD Million)
  • 4.4. Microspheres
    • 4.4.1. Microspheres Market, 2018 - 2030 (USD Million)
  • 4.5. Capsule
    • 4.5.1. Capsule Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Competitive Scenario
    • 5.3.5. Italy
      • 5.3.5.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Competitive Scenario
    • 5.3.6. Spain
      • 5.3.6.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Competitive Scenario
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Competitive Scenario
    • 5.3.9. Norway
      • 5.3.9.1. Norway Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Competitive Scenario
    • 5.4.5. South Korea
      • 5.4.5.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Competitive Scenario
    • 5.4.6. Australia
      • 5.4.6.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Key Country Dynamics
    • 5.5.3. Regulatory Framework
    • 5.5.4. Competitive Scenario
    • 5.5.5. Brazil
      • 5.5.5.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.5.2. Key Country Dynamics
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Competitive Scenario
    • 5.5.6. Mexico
      • 5.5.6.1. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.6.2. Key Country Dynamics
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Competitive Scenario
    • 5.5.7. Argentina
      • 5.5.7.1. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.7.2. Key Country Dynamics
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. Acquisitions
    • 6.2.2. Collaborations
    • 6.2.3. New Platform Launches
    • 6.2.4. Others
  • 6.3. Company Profiles/Listing
    • 6.3.1. Catalent
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Platform Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Lonza
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Platform Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Evonik
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Platform Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Colorcon
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Platform Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Quotient Sciences
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Platform Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Aptar Pharma
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Platform Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Aenova Group
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Platform Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Evotec
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Platform Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Ashland
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Platform Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Vectura Group Ltd.
      • 6.3.10.1. Company Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Platform Benchmarking
      • 6.3.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 4 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 7 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 8 Canada Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 9 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 10 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 11 Germany Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 12 UK Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 13 France Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 14 Italy Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 15 Spain Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 16 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 17 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 18 Norway Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 21 China Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 22 Japan Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 23 India Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 24 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 25 Australia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 26 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 27 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 28 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 29 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 30 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 31 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 34 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 36 UAE Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Gastroretentive Drug Delivery Systems Outsourcing Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Tablets,2018 - 2030 (USD Million)
  • Fig. 16 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Liquid,2018 - 2030 (USD Million)
  • Fig. 17 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Microspheres,2018 - 2030 (USD Million)
  • Fig. 18 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Capsule,2018 - 2030 (USD Million)
  • Fig. 19 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Others,2018 - 2030 (USD Million)
  • Fig. 20 Regional Outlook, 2021 & 2030
  • Fig. 21 North America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 23 Canada Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 24 Europe Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 25 Germany Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 26 UK Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 27 France Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 28 Italy Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 29 Spain Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 30 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 31 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 32 Norway Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 34 Japan Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 35 China Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 36 India Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 37 Australia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 38 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 39 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 40 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 41 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 43 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 44 Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 45 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 47 UAE Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 48 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)